Indication

Acute hepatitis C

Acute hepatitis C is an initial, short-term inflammatory liver infection caused by exposure to the bloodborne hepatitis C virus, conventionally defined as occurring within the first six months following viral acquisition. Read more about Acute hepatitis C

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Acute hepatitis C therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Acute hepatitis C preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute hepatitis C.

Acute hepatitis C is an initial, short-term inflammatory liver infection caused by exposure to the bloodborne hepatitis C virus, conventionally defined as occurring within the first six months following viral acquisition.

Although often asymptomatic, clinical manifestations can include jaundice, dark urine, malaise, abdominal discomfort, and marked elevations in serum aminotransferases.

Pathophysiologically driven by immune-mediated hepatocellular injury rather than direct cytopathic viral effects, the infection spontaneously resolves in a minority of affected individuals but progresses to chronic hepatitis C in the majority if left untreated.

Personalize your experience

Follow Acute hepatitis C and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it